A novel therapeutic approach for the treatment of cerebral cavernous malformation (CCM) was established through targeting the polycomb repressive complex 1 protein CBX7. In CCM, brain endothelial ...
Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced regulatory approval has been ...